{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T08:33:30Z","timestamp":1678955610659},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s00292-010-1357-3","type":"journal-article","created":{"date-parts":[[2010,10,19]],"date-time":"2010-10-19T06:04:58Z","timestamp":1287468298000},"page":"455-463","source":"Crossref","is-referenced-by-count":4,"title":["Heredit\u00e4re Nierenzellkarzinome"],"prefix":"10.1007","volume":"31","author":[{"given":"A.","family":"Hartmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.G.","family":"St\u00f6hr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Junker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,21]]},"reference":[{"key":"1357_CR1","doi-asserted-by":"crossref","first-page":"15552","DOI":"10.1073\/pnas.0603781103","volume":"103","author":"Baba","year":"2006","unstructured":"Baba M, Hong SB, Sharma N et al (2006) Folliculin encodes by the BHD gene interacts with a binding protein. FNIP1, am AMPK, and is involved in AMPK and mTOR signalling. Proc Natl Acad Sci U S A 103:15552\u201315557","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1357_CR2","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/jnci\/djm288","volume":"100","author":"Baba","year":"2008","unstructured":"Baba M, Furihata M, Hong SB et al (2008) Kidney-targeted Birt-Hugg-Dube gene inactivation in a mouse model: Erk1\/2 an Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys. J Natl Cancer Inst 100:140\u2013154","journal-title":"J Natl Cancer Inst"},{"key":"1357_CR3","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrm1261","volume":"4","author":"Birchmeier","year":"2003","unstructured":"Birchmeier C, Birchmeier W, Gherardi E et al (2003) Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4:915\u2013925","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1357_CR4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/01.ju.0000132127.79974.3f","volume":"172","author":"Duffey","year":"2004","unstructured":"Duffey BG, Choyke PL, Glenn G et al (2004) The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J Urol 172:63\u201365","journal-title":"J Urol"},{"key":"1357_CR5","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1038\/sj.onc.1203859","volume":"19","author":"Furge","year":"2000","unstructured":"Furge KA, Zhang YW, Wonnde GF van der et al (2000) Met receptor tyrosine kinase: enhanced signaling through adapter proteins. Oncogene 19:5582\u20135589","journal-title":"Oncogene"},{"key":"1357_CR6","unstructured":"Glasker S (2005) Central nervous system manifestations in VHL: genetics, pathology and clinical Nephrol 19 (Suppl 10):S119\u2013123"},{"key":"1357_CR7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/ncpuro0179","volume":"2","author":"Grubb","year":"2005","unstructured":"Grubb RL III, Choyke PL, Linehan WM et al (2005) Management of von Hippel-Lindau-associated kidney cancer. Nat Clin Pract Urol 2:248\u2013255","journal-title":"Nat Clin Pract Urol"},{"key":"1357_CR8","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.juro.2007.01.155","volume":"177","author":"Gubb","year":"2007","unstructured":"Gubb RL 3rd, Franks ME, Toro J et al (2007) Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. J Urol 177:2074\u20132079","journal-title":"J Urol"},{"key":"1357_CR9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0022-5347(05)66524-X","volume":"165","author":"Herring","year":"2001","unstructured":"Herring JC, Enquist EG, Chernoff A et al (2001) Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10\u00a0year experience. J Urol 165:777\u2013781","journal-title":"J Urol"},{"key":"1357_CR10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ccr.2005.06.017","volume":"8","author":"Isaacs","year":"2005","unstructured":"Isaacs JS, Jung YJ, Mole DR et al (2005) HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: noval role of fumarase in regulation of HIF stability. Cancer Cell 8:143\u2013153","journal-title":"Cancer Cell"},{"key":"1357_CR11","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1097\/01.ASN.0000092803.69761.41","volume":"14","author":"Kaelin","year":"2003","unstructured":"Kaelin WG Jr (2003) The von Hippel-Lindau gene, kidney cancer and oxygen sensing. J Am Soc Nephrol 14:2703\u20132711","journal-title":"J Am Soc Nephrol"},{"key":"1357_CR12","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","volume":"260","author":"Latif","year":"1993","unstructured":"Latif F, Tory K, Gnarra JR et al (1993) Identifications of the von Hippel-Lindau desease tumor suppressor gene. Science 260:1317\u20131320","journal-title":"Science"},{"key":"1357_CR13","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1073\/pnas.051633798","volume":"98","author":"Launonen","year":"2001","unstructured":"Launonen V, Vierimaa O, Kiuru M et al (2001) Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci U S A 98:3387\u20133382","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1357_CR14","unstructured":"Linehan WM, Zbar B, Klausner DR et al (2002) The Metabolic and Molecular Bases of Inherited Disease (OMMBID). McGraw-Hill, New York, Chap 41"},{"key":"1357_CR15","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","volume":"361","author":"Lonser","year":"2003","unstructured":"Lonser RR, Glenn GM, Walther MM et al (2003) Von Hippel-Lindau disease. Lancet 361:2059\u20132067","journal-title":"Lancet"},{"key":"1357_CR16","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0002-9440(10)65147-4","volume":"155","author":"Lubensky","year":"1999","unstructured":"Lubensky IA, Schmidt L, Zhuang Z et al (1999) Hereditary and sporadic papillary renal carcinomas with c-met mutations share a district morphological phenotype. Am J Pathol 155:517\u2013526","journal-title":"Am J Pathol"},{"key":"1357_CR17","unstructured":"Merino MJ, Torres-Cabala CA, Zbar B et al (2003) Hereditary leiomyomatosis and renal cell carcinoma syndromes (HLRCC): clinical, histopathological and molecular features of the first American families described. Modern Pathology USCAP Meeting, Abstracts 16:739"},{"key":"1357_CR18","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0022-5347(01)62509-6","volume":"160","author":"Neumann","year":"1998","unstructured":"Neumann HP, Bender BU, Berger DP et al (1998) Prevalence, morphology and biology of renal cell carcinomas in von Hippel-Lindau disease compared to sporadic renal cell carcinoma. J Urol 160:1248\u20131254","journal-title":"J Urol"},{"key":"1357_CR19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1535-6108(02)00104-6","volume":"2","author":"Nickersen","year":"2002","unstructured":"Nickersen ML, Warren MB, Toro JR et al (2002) Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dub\u00e9 syndrome. Cancer Cell 2:157\u2013164","journal-title":"Cancer Cell"},{"key":"1357_CR20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0022-5347(05)67893-7","volume":"163","author":"Ornstein","year":"2000","unstructured":"Ornstein DK, Lubensky IA, Venzon D et al (2000) Prevalence of microscopic tumors in normal appearing renal parenchym from patients with hereditary papillary renal cancer. J Urol 163:431\u2013433","journal-title":"J Urol"},{"key":"1357_CR21","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/00000478-200212000-00002","volume":"26","author":"Pavlovich","year":"2002","unstructured":"Pavlovich CP, Walther MM, Eyler RA et al (2002) Renal tumors in the Birt-Hogg-Dube syndromes. Am J Surg Pathol 26:1542\u20131552","journal-title":"Am J Surg Pathol"},{"key":"1357_CR22","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1097\/01.ju.0000154629.45832.30","volume":"173","author":"Pavlovich","year":"2005","unstructured":"Pavlovich CP, Grubb RL, Hurley K et al (2005) Evaluation and management of renal tumors in the Birt-Hogg-Dube syndrome. J Urol 173:1482\u20131486","journal-title":"J Urol"},{"key":"1357_CR23","unstructured":"Ries LAG, Melbert D, Krapcho M et al (2008) SEER Cancer Statistics Review 1975\u20132005. National Cancer Institute. Bethesda\/MD"},{"key":"1357_CR24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng0597-68","volume":"16","author":"Schmidt","year":"1997","unstructured":"Schmidt L, Duh FM, Chen F et al (1997) Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 16:68\u201373","journal-title":"Nat Genet"},{"key":"1357_CR25","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1086\/302726","volume":"66","author":"Sgambati","year":"2000","unstructured":"Sgambati MT, Stolle C, Zbar B et al (2000) Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents. Am J Hum Genet 66:84\u201391","journal-title":"Am J Hum Genet"},{"key":"1357_CR26","doi-asserted-by":"crossref","unstructured":"Srinivasan R, Chouciri TK et al (2008) A phase II study of the dual MET\/VEGFR2 inhibitor XL880 in patients (pts) with papillary renal carcinoma (PRC) (abstract) J Clin Oncol 26 (Suppl):5103","DOI":"10.1200\/jco.2008.26.15_suppl.5103"},{"key":"1357_CR27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K","volume":"12","author":"Stolle","year":"1998","unstructured":"Stolle CA, Glenn G, Zbar B et al (1998) Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat 12:417\u2013423","journal-title":"Hum Mutat"},{"key":"1357_CR28","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","volume":"30","author":"Tomlinson","year":"2002","unstructured":"Tomlinson IP, Alam NA, Rowan NA et al (2002) The multiple leiomyoma consortium, germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30:406\u2013410","journal-title":"Nat Genet"},{"key":"1357_CR29","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-5347(17)35015-2","volume":"151","author":"Zbar","year":"1994","unstructured":"Zbar B, Tory K, Merino M et al (1994) Hereditary papillary renal cell carcinoma. J Urol 151:561\u2013566","journal-title":"J Urol"},{"key":"1357_CR30","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0022-5347(01)67601-8","volume":"153","author":"Zbar","year":"1995","unstructured":"Zbar B, Glenn G, Lubensky I et al (1995) Hereditary papillary renal cell carcinoma: clinical studies in 10 families. J Urol 153:907\u2013912","journal-title":"J Urol"},{"key":"1357_CR31","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3","volume":"8","author":"Zbar","year":"1996","unstructured":"Zbar B, Kishida T, Chen F et al (1996) Germline mutations in the (VHL) gene in families from North America, Europe and Japan. Hum Mutat 8(4):348\u2013357","journal-title":"Hum Mutat"},{"key":"1357_CR32","first-page":"393","volume":"11","author":"Zbar","year":"2002","unstructured":"Zbar B, Alvord G, Gienn G et al (2002) Risk of renal and colon neoplasms and spontaneous pneumothorax in the Birt Hogg Dube syndrome. Cancer Epidermiol Biomarkers Prev 11:393\u2013400","journal-title":"Cancer Epidermiol Biomarkers Prev"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-010-1357-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-010-1357-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-010-1357-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:01:06Z","timestamp":1559026866000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-010-1357-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["1357"],"URL":"https:\/\/doi.org\/10.1007\/s00292-010-1357-3","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}